Birchview Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$242K	Hold	14,000	–	–	0.24%	56
2025 Q1	$306K	Hold	14,000	–	–	0.27%	44
2024 Q4	$447K	Hold	14,000	–	–	0.36%	36
2024 Q3	$404K	Hold	14,000	–	–	0.35%	32
2024 Q2	$537K	Sell	14,000 -4,000	-22%	-$153K	0.5%	31
2024 Q1	$1.06M	Hold	18,000	–	–	0.86%	25
2023 Q4	$1.08M	Hold	18,000	–	–	0.84%	27
2023 Q3	$685K	Buy	18,000 +6,000	+50%	+$228K	0.58%	30
2023 Q2	$1.09M	Hold	12,000	–	–	0.82%	21
2023 Q1	$792K	Hold	12,000	–	–	0.62%	24
2022 Q4	$621K	Hold	12,000	–	–	0.44%	29
2022 Q3	$820K	Hold	12,000	–	–	0.58%	31
2022 Q2	$543K	Hold	12,000	–	–	0.4%	36
2022 Q1	$610K	Hold	12,000	–	–	0.44%	37
2021 Q4	$567K	Hold	12,000	–	–	0.37%	41
2021 Q3	$396K	Buy	12,000 +4,000	+50%	+$132K	0.27%	47
2021 Q2	$506K	Hold	8,000	–	–	0.3%	43
2021 Q1	$343K	Hold	8,000	–	–	0.2%	46
2020 Q4	$458K	Hold	8,000	–	–	0.26%	42
2020 Q3	$241K	Hold	8,000	–	–	0.16%	46
2020 Q2	$261K	Hold	8,000	–	–	0.16%	47
2020 Q1	$214K	Hold	8,000	–	–	0.19%	41
2019 Q4	$245K	Buy	+8,000	New	+$245K	0.18%	44
2019 Q3	–	Sell	-8,000	Closed	-$203K	–	51
2019 Q2	$203K	Buy	+8,000	New	+$203K	0.12%	43